Pennsylvania Business Report
Malvern company closes $10M offering to extend Alzheimer’s therapy testing
Annovis Bio, Inc., a biotech company based in Malvern, Pa., announced it had closed on a $10 million underwritten public offering that would allow it to continue development of an oral therapy to treat neurodegenerative diseases. Officials said the company is developing buntanetap as a treatment for conditions Alzheimer's disease (AD) and Parkinson's disease (PD). The public offering, when combined with existing cash on hand and a $1.5 million investment from the Board of Directors Chair, Mi...
Read More
Credit: Eaton
WebFX to create training, meeting facility in Harrisburg
April 13, 2026
David Martin
Woolpert names executive vice president of global operations
April 10, 2026
Saladax Biomedical signs distribution agreement
April 9, 2026
Pixelle Specialty Solutions launches AI platform
April 9, 2026
Legislation would create scholarship for skilled trades
April 8, 2026
PIDA approves $4.3 million in loans
April 6, 2026
